E
Sol-Gel Technologies Ltd. SLGL
$7.00 -$0.85-10.83% NASDAQ
Recommendation
Prev Close
$7.85
Volume
6,517
Avg Vol (90D)
26,060
Market Cap
$21.87M
Dividend & Yield
--
52-Week Range
$3.34 - $16.50
P/E (TTM)
--
EPS (TTM)
-$1.39
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Sol-Gel Technologies (NASDAQ:SLGL) Stock Price Down 39.5% - Should You Sell?
5/8/2025 - MarketBeat
Insider Buys Additional US$98k In Sol-Gel Technologies Stock
5/2/2025 - Simply Wall St
Sol-Gel Technologies (SLGL) Announces 10-for-1 Reverse Stock Split SLGL Stock News
5/1/2025 - GuruFocus
Sol-Gel Technologies announces 10-for-1 reverse share split
5/1/2025 - The Fly
Sol-Gel Announces Reverse Share Split
5/1/2025 - Globe Newswire
Sol-Gel Technologies files $120M mixed securities shelf
4/29/2025 - TipRanks Financial Blog
Sol-Gel Technologies files $120M mixed securities shelf
4/29/2025 - The Fly
Sol-Gel Technologies (SLGL) Secures Licensing Deal, Eyes U.S. Market with SGT-610 MAYNF Stock News
4/17/2025 - GuruFocus
Sol-Gel, Mayne Pharma enter product purchase agreement
4/17/2025 - TipRanks Financial Blog
Sol-Gel and Mayne Pharma Announce the Purchase of EPSOLAY and TWYNEO in the U.S.
4/17/2025 - Globe Newswire
Investors Don't See Light At End Of Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Tunnel And Push Stock Down 31%
4/11/2025 - Simply Wall St
Sol-Gel Technologies (NASDAQ:SLGL) Stock Price Up 5.2% - Here's What Happened
3/29/2025 - Ticker Report
Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Short Interest Update
2/12/2025 - Ticker Report
Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Not Doing Enough For Some Investors As Its Shares Slump 51%
2/7/2025 - Simply Wall St
Is SolGel Technologies (SLGL) a Great Value Stock Right Now?
12/25/2024 - Zacks Investment Research
There's Reason For Concern Over Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Massive 209% Price Jump
12/24/2024 - Simply Wall St
Sol-Gel Technologies Third Quarter 2024 Earnings: Beats Expectations
11/21/2024 - Simply Wall St
SolGel Technologies (SLGL) Upgraded to Buy: Here's What You Should Know
11/20/2024 - Zacks Investment Research
Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement
11/20/2024 - Globe Newswire
Sol-Gel Technologies Ltd. (SLGL) Reports Q3 Loss, Tops Revenue Estimates
11/15/2024 - Zacks Investment Research
Sol-Gel Technologies Reports Positive Q3 Financials and Strategic Moves
11/15/2024 - TipRanks Financial Blog
Sol-Gel Technologies reports Q3 EPS (1c) vs (23c) last year
11/15/2024 - The Fly
Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
11/15/2024 - Globe Newswire
Analysis of ARMISTICE CAPITAL, LLC's Recent Transaction in Sol-Gel Technologies Ltd
11/15/2024 - GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
$35.85M
Total Debt (Q)
$1.31M
Total Liabilities (Q)
$7.00M
Book Value Per Share (Q)
$10.36
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Tuesday, April 29, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of Aug 11 and 15 (est)
Price History
Loading...
Beta
2.78
7-Day Total Return
-9.56%
30-Day Total Return
27.27%
60-Day Total Return
13.62%
90-Day Total Return
-37.50%
Year to Date Total Return
-31.03%
1-Year Total Return
0.24%
2-Year Total Return
-80.09%
3-Year Total Return
-88.31%
5-Year Total Return
-92.18%
52-week Low
Aug 05, 2024 - $3.34
52-week High
Dec 23, 2024 - $16.50
Valuation
Market Cap
$21.87M - Nano Cap
Enterprise Value
-$749.77K
Price/Sales (TTM)
3.83
Price/Book (Q)
0.76
Dividends and Shares
Shares Outstanding
2.79M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.sol-gel.com
Phone Number
972 8 931 3433
Address
7 Golda Meir Street
Ness Ziona, 7403650
Country
Israel
Year Founded
1997
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers... more
NASDAQ 05/12/2025 10:39AM Eastern Quotes delayed